Daniel Hume's most recent trade in TG Therapeutics Inc was a trade of 62,459 Common Stock done . Disclosure was reported to the exchange on March 17, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
TG Therapeutics Inc
|
Daniel Hume | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Mar 2025 | 62,459 | 178,030 (0%) | 0% | 0 | Common Stock | |
TG Therapeutics Inc
|
Daniel Hume | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2024 | 22,250 | 240,489 (0%) | 0% | 0 | Common Stock | |
TG Therapeutics Inc
|
Daniel Hume | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2020 | 15,000 | 134,507 (0%) | 0% | 0 | COMMON STOCK |